feedback

Course Director

Rohit Katial, MD
Rohit Katial, MD

National Jewish Health
University of Colorado
Denver, Colorado

Accredited by

Medical Learning Institute, Inc.

View Activity Materials

Activity Details

Credit Types:CME
Credit Amount:0.5 Credits
Release Date:2017-Mar-16
Expiration Date:2018-Mar-15
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free of charge
Activity Description and Educational Objectives
In this activity, a renowned expert in allergic diseases narrates a guided tour of an infographic reviewing the identification and treatment of pediatric patients with uncontrolled allergic asthma.

Upon completion of this activity, participants should be better able to:
  • Apply approaches to identify pediatric patients with uncontrolled allergic asthma
  • Select treatments for pediatric patients with uncontrolled allergic asthma based on evidence-based guidelines and individual patient profile
  • Identify new treatments for uncontrolled pediatric allergic asthma in terms of their mechanism of action, efficacy, and safety

Target Audience
This activity has been designed to meet the educational needs of allergists, immunologists, pediatricians, and other clinicians involved in the management of pediatric patients with allergic asthma.

Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: March 16, 2017 - March 15, 2018
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME activity for any amount during the past 12 months.

Course Director
Rohit Katial, MD
Professor of Medicine
Associate Vice President for Clinical Research and Industry Relationships
Co-director, The Cohen Family Asthma Institute at National Jewish Health
Helen Wohlberg & Herman Lambert Chair in Pharmacokinetics
National Jewish Health
University of Colorado
Denver, Colorado

Rohit Katial, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board for AstraZeneca; CSL Behring; and Teva Pharmaceuticals USA.

Rohit Katial, MD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: treatments used off-label for asthma.

CME Reviewers
Norman L. Koven, MD
Aria Health
Philadelphia, Pennsylvania

Norman L. Koven, MD, has no financial interests/relationships or affiliations in relation to this activity.

Kaushal Patel, MD
Nephrology Associates of Central PA
Camp Hill, Pennsylvania

Kaushal Patel, MD, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director
Kate Nelson, PhD
PVI, PeerView Institute for Medical Education

Kate Nelson, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer
The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Providership
This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support
This activity is supported by educational grants from Genentech and Novartis Pharmaceuticals Corporation.

Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

Copyright © 2000-2017, PeerView Press - Medical Education Resource

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.